{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"groups":[{"description":"Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.","id":"OG000","title":"Arm I"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"At baseline","title":"Number of Patients With Elevated Labile Plasma Iron (LPI) Above Threshold (0.5 Umol/L)","type":"PRIMARY","unitOfMeasure":"Participants"}